Review decision date: November 2014

Review decision: 

Following the recent surveillance review which checks the need to update CG153, this guideline should not be updated at this time. This guideline will be checked again for update at its scheduled time point according to the methods described here.

Next review date: February 2017

This clinical guideline (published October 2012) offers evidence-based advice on the assessment and management of psoriasis in adults, young people and children.

This guideline was previously called psoriasis: the assessment and management of psoriasis.

Your responsibility

The recommendations in this guideline represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, professionals are expected to take this guideline fully into account, alongside the individual needs, preferences and values of their patients or service users. The application of the recommendations in this guideline is not mandatory and the guideline does not override the responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or their carer or guardian.

Local commissioners and/or providers have a responsibility to enable the guideline to be applied when individual health professionals and their patients or service users wish to use it. They should do so in the context of local and national priorities for funding and developing services, and in light of their duties to have due regard to the need to eliminate unlawful discrimination, to advance equality of opportunity and to reduce health inequalities. Nothing in this guideline should be interpreted in a way that would be inconsistent with compliance with those duties.

  • National Institute for Health and Care Excellence (NICE) accreditation logo